#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18446	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2049	893.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1397	1397	C	1146	C,A	1026,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18446	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2049	893.1	0	HET	.	.	.	C451T,A	.	451	451	C	664	664	C	1031	C,T,A	681,263,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34192	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3614	942.9	0	.	n	.	0	T695C	SNP	695	695	T	1160	1160	C	1067	C,T	944,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34192	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3614	942.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2436	2436	C	1134	C,T	1002,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34192	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3614	942.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2510	2510	A	1043	A	939	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34192	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3614	942.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3062	3062	C	1066	C,T	959,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	34192	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3614	942.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2103	2103	A	1086	A,G	572,413	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2586	folP	855	855	100.0	folP.l15.c4.ctg.1	1372	187.2	1	SNP	p	R229S	1	.	.	685	687	AGC	957	959	AGC	290;288;285	A;G;C	260;256;251	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3315	206.5	1	SNP	p	S91F	1	.	.	271	273	TTC	563	565	TTC	232;229;229	T;T;C	210;205;205	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3315	206.5	1	SNP	p	D95G	1	.	.	283	285	GGC	575	577	GGC	233;233;237	G;G;C	215;214;218	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6874	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3315	206.5	1	SNP	p	G95N	0	.	.	283	285	GGC	575	577	GGC	233;233;237	G;G;C	215;214;218	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1916	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1352	141.1	1	SNP	p	G45D	0	.	.	133	135	GGC	513	515	GGC	259;257;257	G;G;C	234;229;229	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	966	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1095	87.8	0	.	n	.	0	A197.	DEL	197	197	A	603	603	A	230	A	203	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2740	231.2	1	SNP	p	D86N	0	.	.	256	258	GAC	474	476	GAC	241;240;239	G;A;C	212;203;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2740	231.2	1	SNP	p	S87R	1	.	.	259	261	CGT	477	479	CGT	238;236;236	CG,C;G;T,C	217,1;212;211,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2740	231.2	1	SNP	p	R87I	0	.	.	259	261	CGT	477	479	CGT	238;236;236	CG,C;G;T,C	217,1;212;211,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2740	231.2	1	SNP	p	R87W	0	.	.	259	261	CGT	477	479	CGT	238;236;236	CG,C;G;T,C	217,1;212;211,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6368	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2740	231.2	1	SNP	p	S88P	0	.	.	262	264	TCC	480	482	TCC	234;234;234	T;C;C	214;212;214	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5384	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2609	205.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1547	1549	GGC	267;265;263	G;G;C	232;231;227	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1124	1126	GCC	271;272;276	G;C;C,A	244;244;247,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1127	1129	ATG	278;280;279	A;T;G	253;252;247	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1139	1141	ACC	277;276;278	A;C;C	252;252;254	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1139	1141	ACC	277;276;278	A;C;C	252;252;254	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1640	1642	ACC	288;286;286	A,T,G;C;C	237,1,1;245;247	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1694	1696	GCG	256;257;257	G;C;G	222;221;221	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1694	1696	GCG	256;257;257	G;C;G	222;221;221	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1817	1819	GGT	227;226;225	G;G;T	189;192;187	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1826	1828	AGC	222;222;218	A;G;C	185;187;183	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5108	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2176	233.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1844	1846	CCG	198;198;202	C,G;CG,CGGG;G	138,7;135,1;150	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7000	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3095	225.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1591	1593	CCG	249;249;251	C,T;C;G	219,1;229;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2658	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1853	142.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	627	627	C	198	C	172	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3520	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	221.2	1	SNP	p	G120K	1	.	.	358	360	AAG	631	633	AAG	289;287;286	A;A;G	259;257;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3520	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	221.2	1	SNP	p	A121N	1	.	.	361	363	AAC	634	636	AAC	287;284;283	A;A;C,A	257;259;253,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3520	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1585	221.2	1	SNP	p	N121D	0	.	.	361	363	AAC	634	636	AAC	287;284;283	A;A;C,A	257;259;253,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13542	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4852	278.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1440	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	898	158.8	1	SNP	p	V57M	1	.	.	169	171	ATG	452	454	ATG	289;289;293	A;T,A;G	255;253,1;258	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
